Inventiva (IVA) Cash & Equivalents (2018 - 2025)
Inventiva (IVA) recorded quarterly Cash & Equivalents of $115.6 million in Q4 2025, up 5.75% quarter-over-quarter from $109.3 million in Q2 2025, and up 11.98% on a YoY basis from $103.2 million in Q4 2024.
Inventiva (IVA) Cash & Equivalents (2018 - 2025) Analysis & Trends
Inventiva's Cash & Equivalents history runs 8 years deep, the most recent figure standing at $115.6 million for Q4 2025.
- In Q4 2025, Cash & Equivalents rose 11.98% year-over-year to $115.6 million; the TTM figure through Dec 2025 stood at $115.6 million (up 11.98% YoY), while the FY2025 annual figure was $115.6 million, up 11.98% from the prior year.
- Cash & Equivalents was $115.6 million for Q4 2025 at Inventiva, up from $109.3 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $130.0 million in Q1 2021 to a low of $9.7 million in Q4 2023.
- Historically, Cash & Equivalents has averaged $84.7 million across 5 years, with a median of $94.4 million in 2023.
- The sharpest annual moves came in 2023 and 2024: Cash & Equivalents sank 89.08% in 2023, then soared 967.79% in 2024.
- A 5-year view of Cash & Equivalents shows it stood at $99.0 million in 2021, then fell by 10.63% to $88.5 million in 2022, then tumbled by 89.08% to $9.7 million in 2023, then surged by 967.79% to $103.2 million in 2024, then gained by 11.98% to $115.6 million in 2025.
- The last three Cash & Equivalents figures came in at $115.6 million (Q4 2025), $109.3 million (Q2 2025), and $103.2 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 1.91 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 2.77 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 18.44 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 7.15 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 5.49 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 558.94 Mn |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | 115.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 115.59 Mn |
| Jun 30, 2025 | 109.31 Mn |
| Dec 31, 2024 | 103.23 Mn |
| Jun 30, 2024 | 28.99 Mn |
| Dec 31, 2023 | 9.67 Mn |
| Oct 11, 2023 | 12.54 Mn |
| Jun 30, 2023 | 94.45 Mn |
| Dec 31, 2022 | 88.49 Mn |
| Sep 22, 2022 | 90.31 Mn |
| Jun 30, 2022 | 92.36 Mn |
| Dec 31, 2021 | 99.01 Mn |
| Jun 30, 2021 | 127.28 Mn |
| Mar 31, 2021 | 130.04 Mn |
| Dec 31, 2020 | 126.01 Mn |
| Jun 30, 2020 | 57.58 Mn |
| Mar 31, 2020 | 51.77 Mn |
| Dec 31, 2019 | 39.67 Mn |
| Dec 31, 2018 | 64.71 Mn |